4 ms·
My mother was diagnosed with endometrial cancer at the start of 2020. If you haven’t known someone diagnosed with cancer recently, it might not be obvious how a
by graypegg 3y ago
My mother was diagnosed with endometrial cancer at the start of 2020. If you haven’t known someone diagnosed with cancer recently, it might not be obvious how advanced cancer treatment and care is now. You see so many stories about new cancer treatments or prevention strategies all the time, and it’s so easy to discount it as just more spam, but we’re getting extremely good at making people better, even in comparison to as recently as a decade ago. Not perfect, but the trajectory is very steep.
(Disclaimer, I’m not an expert, I was just pretty amazed by how the whole process was customized and targeted for her specific case.)
I’m sure this isn’t a catch-all, and it’s bad to put hope in “one thing to solve it all”, but this sure is exciting.
- johntiger1 3y agoHow is your mother doing now? My mom unfortunately passed away from stage C liver cancer, so still a lot of advancement to be made
- graypegg 3y agoI’m deeply sorry. Cancer is a horrible disease. She’s doing better, only about a year off treatment currently. It was originally found at stage 3 but it seems that surgery + 2 radiation rounds + 2 chemo rounds has worked alright.
- denimnerd42 3y agoSome cancer treatments have advanced a lot. Some are still using the same old drugs. Mother with StageIIIc ovarian in 2019 resection, HIPEC, then chemo. Recurrence in 2020 and every 6-9mo after that with some areas appearing, others shrinking. Platinum resistant in 2022 (many many many different times combined with taxol, doxil, etc). Taxol alone not working now as she had a spread event. Doxil + Avastin is now being tried (again but without platinum). Probably out of options sooner or later even though she can physically handle more chemo. Avastin is pretty much the only advance for this cancer and it's not very good. She's been on it on and off several times with the other chemo drugs. Of course all this depends on the mutations and such. Hers aren't ones anything new if it exists works for. This is a major research hospital with distinguished specialists.
- khuey 3y agoYeah "cancer" is a variety of diseases and treatments for some of those diseases have advanced very far and others haven't changed much.
- pfannkuchen 3y agoIs it a variety of diseases, or do the different colonies of organ-specific cells just behave differently once they are unleashed?
- stvltvs 3y agoDifferent diseases. Not every colon cancer, for example, behaves the same. And if colon cancer spreads to the lungs, it's still colon cancer, not lung cancer.
- pfannkuchen 3y agoThere are different cell types in the colon, and I would expect a colony of each cell type to behave differently. Cancer is like a bacterial infection, but with cells from the host. Of course if your lung has an infection of colon cells those don’t suddenly become lung cells. I don’t see how that makes it different diseases. It is only treated that way because we aren’t attacking the root cause (i.e. the actual broken replication inhibitor in whatever line of cells).
- unaindz 3y agoBy my honestly shallow understanding of cancer it's not that simple. For the cancer to not get killed immediately several things have to get broken, not just the replication inhibitor. Once they get to that state is not far fetched to think that they can have or get in the future different mutations, not specifically required to get cancer in the first place. The comments below us talk about the folate receptor mutation that not all cancers have.
- drpgq 3y agoAs a Canadian I wonder how available this new stuff is here.
- graypegg 3y agoShe lives in Oshawa Ontario, went to lakeridge health cancer centre. As for if this cancer screening process from the root post is available, I’m not sure.
- arcticbull 3y agoCancer outcomes in Canada are approximately the same as in the US. Give or take. Some are better in Canada, some better in the US. > Conclusions: Among younger Canadian cancer patients in the lowest SES group, greater access to health care may have resulted in higher cancer survival, while higher screening prevalence and access to health insurance (Medicare) among older Americans during the period of this study may have resulted in higher survival for some screen-detected cancers. Higher survival in the highest SES group for stomach and liver may relate to treatment differences. [1] This study breaks it down by type, and socioeconomic status too, if you're curious. This is just one more recent study, but there's a lot of evidence to support this. [edit] Note that 5-year survival rate comparisons tend to benefit the US because the US does more aggressive testing. Studies show that this testing often doesn't actually reduce mortality, but it does start the 5-year survival clock earlier. So odds are this data overstates the outcomes in the US, particularly in the older demographic as the conclusion calls out. But that's a conversation for another time. [1] https://www.naaccr.org/wp-content/uploads/2022/07/NCRA-Spring-2022_v3.2_links_25-35-3.pdf https://www.naaccr.org/wp-content/uploads/2022/07/NCRA-Sprin...
- refurb 3y agoWow, for things like prostate cancer, the 5-year survival rate in the US is 10% higher, even for the lowest SES.
- arcticbull 3y agoFor liver cancer it's about 15% higher in Canada for all SES, 10% higher for cervical cancers - and for all childhood cancers it's 5-10% higher in Canada depending on SES. For prostate cancer specifically, that's likely due to higher screening rate guidelines in the US leading to earlier detection, not lower mortality. Prostate cancer comes up a lot because it's often used as a stalking horse, and it's generally a disease of the elderly. [1] Specifically it came up in re: Guiliani and the UK: > For one thing, according to the American Cancer Society, many more men are screened for prostate cancer in the U.S. than in Britain. This leads to more cases being diagnosed. And many who have prostate cancer live for years, without treatment, whether they are diagnosed or not. Thus, a higher number of diagnoses leads to a higher official survival rate. But this tells us nothing about the quality of treatment available to those who have the disease. A spokesman for the ACS told us that comparing rates in the two countries is “misleading.” There have been evaluations of this between the US and Canada [2] > US and Canadian differences in screening due to guidelines can potentially explain cross-country differences in breast cancer mortality and affect interpretation of international comparisons of cancer statistics. The outcomes really are very comparable in the two systems, despite them trading top spots in different categories. [1] https://www.factcheck.org/2007/10/a-bogus-cancer-statistic/ https://www.factcheck.org/2007/10/a-bogus-cancer-statistic/ [2] https://academic.oup.com/intqhc/article/23/6/611/1819867 https://academic.oup.com/intqhc/article/23/6/611/1819867
- slacknatcher12 3y agoYep. Even with "old drugs" the new programs using those give significantly better chances than with the old programs. Year of data collecting sure have given results. I had testicular cancer in 2006 in Chile. I was a teenager so I went with the public system (AUGE back then). My parents friends were giving the condolences for my soon to occur death. The doctors had a laugh as in the last 10 years (by then) my chances of dying of it became basically nil. Last year we hired a new guy at $JOB that 1 week after being hired was diagnosed with testicular cancer too. He really thought he was gonna die. He was at stage 4 (which is a highly zone specific metric). Last time I saw him he is still coding and more bald. It was more difficult to sort payments than the treatment as he is in the US.
- sowbug 3y agoMost testicular cancer is now reliably curable by harsh but effective chemotherapy. Mission accomplished? Not quite. Curative drugs such as cisplatin are scarce. Their patents are long-expired, so they're less profitable to manufacture, so manufacturers don't manufacture them. Hooray for the free market.
- gnulinux 3y agoMy uncle (<60, healthy) was diagnosed with pancreatic cancer. Although they used extremely expensive wonder drugs, personalized drugs targeting his cancer cells etc, they were completely ineffective and he died less than 11 months after the diagnosis. He was extremely healthy and athletic at the beginning of 2022, and looked basically like a skeleton by the end of it. Cancer is a terrible disease and although we made incredible, awe-inspiring amount of process, we still have some way to go. Of course, I understand that pancreatic cancer is a particularly nasty cancer, one of the worst.
- denhaus 3y agoSorry to hear that. I had an uncle die from lung cancer (smoker, but otherwise healthy) about a decade ago. I know how horrifying the process is. Hope you have been able to process your grief.
- tsuujin 3y agoI lost my dad to prostate cancer last year with much the same timeline. Healthy as could be, out surfing and building decks and shit one day, dead a year later. Cancer sucks.
- maxioatic 3y agoReally sorry for your loss. My dad died of cancer about 20 years ago when I was pretty young. It has gotten easier over the years, but still, sometimes it feels like grief punches me in the sternum. Wishing you the best.
- tsuujin 3y agoI appreciate that. I have my good days and my bad days. Nothing to do but keep on going.
- bsder 3y ago> You see so many stories about new cancer treatments or prevention strategies all the time, and it’s so easy to discount it as just more spam, but we’re getting extremely good at making people better, even in comparison to as recently as a decade ago. IF we catch the cancer early, we are much better at treatments. What we are getting good at is treatment with early detection because we can just cut it out with surgery. What we are only marginally better at is treatment with late detection. For cancers that we don't have early detection, the success rates are far, far lower and the treatments are far more limited. For example, a significant fraction of women get diagnose with lobular breast cancer--it doesn't form lumps. So by the time you detect it, you are almost always already Stage 3 or worse. Radiation, in particular, is much better thanks to computing. The only advance in surgery I have seen since the 1970s is that they use a radioctive marker to trace where the lymph nodes are--it helps with lympedema but not the cancer. Chemotherapy is only marginally better than 20 years ago--they're a little better at managing side effects but chemo is still horrible. Medicine does well on things that can be fixed by physical means--cutting things out or sewing things together. Medicine still doesn't do all that well from a chemical standpoint.
- nabbe23 3y agoThis really hits the nail on the head, so many people miss this. Didn't realize myself until I was diagnosed with a sarcoma (1% of adult cancer diagnoses), MPNST (a single digit percentage of sarcomas). Doctors scrambled to figure out what to do - first we should just cut it out, then, well maybe we should do chemo + radiation. A day before getting a port put in receive a phone call that "oops, chemo doesn't work, just cut it out and radiation afterwards." Luckily I was in a good position to get multiple opinions and read the data myself. Almost 2 years cancer free now and am so grateful, but looking at the data, it's all seems like a toss up unless you can just cut it out with clean margins. I really can't help but think modern medicine is really missing the mark with the reactionary approach to disease in general, but of course I have no clue what to do about it.
- bsder 3y ago> I really can't help but think modern medicine is really missing the mark with the reactionary approach to disease in general, but of course I have no clue what to do about it. There are two hard problems here: 1) Medicine doesn't always have anything good to actually do As you point out, there was nothing other than cut it out and do radiation for your case. Those are very physical processes. Chemical processes that either do something directly to problematic cells or cause the body to do something to problematic cells are very lacking. We don't have very many knobs that do something to diseased cells that don't also do horrible things to the patient. 2) The source of being "reactionary" is that statistically rare diseases show up as false positives way more often than real positives without some Bayesian prior. Medical testing is a balance between causing too much harm in testing and not enough detection. Lobular breast cancer only shows up on MRI. So, women should get an MRI with their mammogram, right? Well, except that the MRI requires a gadolinium contrast which bioaccumulates. And you needed an IV for the contrast which can get infected. And, you will find a lump of something with a modern MRI. Now what? You really should leave it alone and watch it, but some women will be unable to deal with the anxiety so you will need to biopsy it. Biopsies have their own problems. etc. Testing for infrequent events is hard.
- poulsbohemian 3y agoMy mother-in-law passed away in 2007 within just a few months of her diagnosis, whereas today I suspect that same melanoma today would likely be entirely treatable. My father-in-law passed in 2015 from leukemia, and while I suspect things have improved, my understanding is that treatment outcomes are better for younger patients. Another extended family member was able to fight lung cancer for more than a decade. While we will likely never have a "cure" and from one type to the next the treatments and outcomes vary, I'd certainly agree that it's clear we are making big strides.
- tmaly 3y agoMy friend works at Moderna. We were taking a walk and he mentioned they have cancer vaccines. I had no idea they existed. I guess the only people that have access to them are people in stage 4 cancer where all treatment options have run out. And even this group is small.